Experience with anxiety and depression treatment studies: Implications for designing irritable bowel syndrome clinical trials

American Journal of Medicine

Volumn 107, Issue 5 SUPPL. 1, 1999, Pages 65-73

  Lydiard, R Bruce ^a   Falsetti, Sherry A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; DESIPRAMINE; FLUPHENAZINE; NORTRIPTYLINE; TRIMIPRAMINE MALEATE;

ANXIETY; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; GASTROINTESTINAL SYMPTOM; HEALTH SERVICE; HUMAN; IRRITABLE COLON; MENTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; STRESS; TREATMENT OUTCOME;

EID: 0032740097     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00082-0     Document Type: Article

References (78)

1. Drossman D.A., Lowman B.C. Irritable bowel syndrome epidemiology, diagnosis and treatment . Clin Gastroenterol. 14:1985;559-573.
2. Thompson W.G., Heaton K.W. Functional bowel disorders in apparently healthy people. Gastroenterology. 79:1980;283-288.
3. Drossman D.A., Li Z., Andruzzi E., et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 38:1993;1569-1580.
4. Whitehead W.E., Schuster M.M. Gastrointestinal Disorders Behavioral and Physiological Basis for Treatment . 1985;Academic Press, New York.
5. Norton N. Functional bowel disorders survey. Participate. 6:1997;1-3.
6. Drossman D.A., Thompson W.G., Talley N.J., et al. Identification of subgroups of functional gastrointestinal disorders. Gastroenterol Int. 3:1990;159-172.
7. Manning A.P., Thompson W.G., Heaton K.W., Morris A.F. Towards positive diagnosis of the irritable bowel. BMJ. 2:1978;653-654.
8. Fielding JF. The irritable bowel syndrome. Part I: clinical spectrum. Clin Gastroenterol 1977;6:607-622.
9. Hislop I.G. Psychological significance of the irritable colon syndrome. Gut. 12:1971;452-457.
10. Drossman D.A., McKee D.C., Sandler R.S., et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology. 95:1988;701-708.
11. Sandler R.S., Drossman D.A., Nathan H.P., McKee D.C. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology. 87:1984;314-318.
12. Whitehead W.E., Bosmajian L., Zonderman A.B., Costa P.J., Schuster M.M. Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology. 95:1988;709-714.
13. Esler M.D., Goulston K.J. Levels of anxiety in colonic disorders. N Engl J Med. 288:1973;16-20.
14. Clouse R.E., Alpers D.H. The relationship of psychiatric disorder to gastrointestinal illness. Annu Rev Med. 37:1986;283-295.
15. Blanchard E.B., Scharff L., Schwarz S.P., Suls J.M., Barlow D.H. The role of anxiety and depression in the irritable bowel syndrome. Behav Res Ther. 28:1990;401-405.
16. Fava GA, Pavan L. Large bowel disorders. II. Psychopathology and alexithymia. Psychother Psychosom 1976;27:100-105.
17. Ford M.J., Miller P.M., Eastwood J., Eastwood M.A. Life events, psychiatric illness and the irritable bowel syndrome. Gut. 28:1987;160-165.
18. Latimer PR. Irritable bowel syndrome: a behavioral model. Behav Res Ther 1981;19:475-483.
19. Liss J.L., Alpers D., Woodruff R.J. The irritable colon syndrome and psychiatric illness. Dis Nerv Syst. 34:1973;151-157.
20. Lydiard R.B., Fossey M.D., Marsh W., Ballenger J.C. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics. 34:1993;229-234.
21. Walker E.A., Roy B.P., Katon W.J., Li L., Amos D., Jiranek G. Psychiatric illness and irritable bowel syndrome a comparison with inflammatory bowel disease . Am J Psychiatry. 147:1990;1656-1661. [see comments].
22. Wender P.H., Kalm M. Prevalence of attention deficit disorder, residual type, and other psychiatric disorders in patients with irritable colon syndrome. Am J Psychiatry. 140:1983;1579-1582.
23. Toner B.B., Garfinkel P.E., Jeejeebhoy K.N. Psychological factors in irritable bowel syndrome. Can J Psychiatry. 35:1990;158-161.
24. Young S.J., Alpers D.H., Norland C.C., Woodruff R.J. Psychiatric illness and the irritable bowel syndrome. Practical implications for the primary physician. Gastroenterology. 70:1976;162-166.
25. Whitehead W.E. Psychosocial aspects of functional gastrointestinal disorders. Gastroenterol Clin North Am. 25:1996;21-34.
26. Drossman DA. Psychosocial considerations in gastroenterology. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, 5th Ed. Philadelphia: WB Saunders, 1993;3-17.
27. Walker EA, Gelfand AN, Gelfand MD, Katon WJ: Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychol Med 1995;25:1259-1267.
28. Drossman DA, Sandler RS, McKee DC, Lovitz AJ: Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 1982;83:529-534.
29. Drossman D.A., Leserman J., Nachman G., Li Z.M., Gluck H., Toomey T.C., Mitchell T.C. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med. 113:1990;828-833.
30. Felliti V. Long term medical consequences of incest, rape and molestation. South Med J. 84:1991;328-331.
31. Lechner M., Vogel M., Garcia-Shelton L., Leichter J., Steibel K. Self-reported medical problems of adult female survivors of childhood sexual abuse. J Family Pract. 36:1993;633-638.
32. Talley NJ, Hegelson S, Zinsmeister AR. Are sexual and physical abuse linked to functional gastrointestinal disorders? Gastroenterology 1992;102:A523. Abstract.
33. Scarinci I.C., Haile J.M., Bradley L.A., Richter J. Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse. Am J Med. 97:1994;108-118.
34. Walker E.A., Katon W.J., Roy B.P., Jemelka R.P., Russo J. Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry. 150:1993;1502-1506.
35. Irwin C., Falsetti S.A., Lydiard R.B., Ballenger J.C., Brock C.D., Brener W. Comorbidity of post traumatic stress disorder and irritable bowel syndrome. J Clin Psychiatry. 57:1996;576-578.
36. Arnold R., Rogers D., Cook D. Medical problems of adults who were sexually abused as children. BMJ. 300:1990;705-708.
37. Bachman G., Moeller T., Bennett J. Childhood sexual abuse and the consequence in adult women. Obstet Gynecol. 71:1988;631-642.
38. Haber J., Roos C. Effects of chronic spouse abuse and or sexual abuse in the development and maintenance of pain in women. Adv Pain Res Ther. 9:1985;889-895.
39. Rimza M., Berg R., Locke C. Sexual abuse somatic and emotional reactions . Child Abuse Negl. 12:1988;201-208.
40. Sedney M., Brooks B. Factors associated with a history of childhood sexual experience in a nonclinical female population. J Am Acad Child Adolesc Psychiatry. 9:1984;889-895.
41. Lydiard R.B., Greenwald S., Weissman M.M., Johnson J., Drossman D.A., Ballenger J.C. Panic disorder and gastrointestinal symptoms findings from the NIMH Epidemiologic Catchment Area project . Am J Psychiatry. 151:1994;64-70.
42. Robins L., Regier D. Psychiatric Disorders in America. 1991;The Free Press, New York.
43. American Psychiatric Association. Diagnostic and Statisti-cal Manual for Mental Disorders, 4th Ed. Washington, DC: American Psychatric Press, 1994.
44. Gershon M.D. The enteric nervous system. Annu Rev Neurosci. 4:1981;227-272.
45. Coplan J, Lydiard RB. Brain Circuits in Panic Disorder. Biolo Psychiatry 1998;44:1264-1276.
46. Charney D.S., Heninger G.R. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry. 43:1986;1042-1054.
47. Uhde T.W., Boulenger J.P., Post R.M., et al. Fear and anxiety relationship to noradrenergic function . Psychopathology. 3:1984;8-23.
48. Elam M., Swensson T., Thoren P. Locus ceruleus in sympathetic nerves activation by visceral afferents . Brain Res. 375:1986;117-125.
49. Mayer E.A. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology. 107:1994;271-293.
50. Lydiard R.B., Laraia M.T., Howell E.F., Ballenger J.C. Can panic disorder present as irritable bowel syndrome? J Clin Psychiatry. 47:1986;470-473.
51. Lydiard RB, Fossey MD, Ballenger JC. Irritable bowel syndrome in patients with panic disorder. Am J Psychiatry 1991;148:1614. Letter [comment].
52. Noyes R.J., Cook B., Garvey M., Summers R. Reduction of gastrointestinal symptoms following treatment for panic disorder. Psychosomatics. 31:1990;75-79.
53. Tollefson G.D., Luxenberg M., Valentine R., Dunsmore G., Tollefson S.L. An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder. J Clin Psychiatry. 52:1991;502-508.
54. Kaplan D.S., Masand P.S., Gupta S. The relationship of irritable bowel syndrome (IBS) and panic disorder. Ann Clin Psychiatry. 8:1996;81-88.
55. Dewsnap P., Gomborone J., Libby G., Farthing M. The prevalence of symptoms of irritable bowel syndrome among acute psychiatric inpatients with an affective diagnosis. Psychosomatics. 37:1996;385-389.
56. Masand P.S., Kaplan D.S., Gupta S., Bhandary A.N. Irritable bowel syndrome and dysthymia. Is there a relationship? Psychosomatics. 38:1997;63-69.
57. Masand PS, Kaplan DS, Gupta S, et al. Major depression and irritable bowel syndrome: Is there a relationship? J Clin Psychiatry 1995;56:363-367.
58. Toner B.B., Stuckless N., Ali A., Downie F., Akman E.S.D. The development of a cognitive scale for functional bowel disorders. Psychosom Med. 60:1998;492-497.
59. Drossman D.A. Presidential address gastrointestinal illness and the biopsychosocial model . Psychosom Med. 69:1998;258-267.
60. Whorwell P.J., Prior A., Colgan S.M. Hypnotherapy in severe irritable bowel syndrome further experience . Gut. 28:1987;423-425.
61. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders 3rd ed, rev. Washington, DC: American Psychatric Press, 1987.
62. Spitzer R, Williams J, Gibbon M, First M. Structured Clinical Interview for DSM-IIIR. Washington, DC: American Psychiatric Association Press, Inc., 1990.
63. Heefner J.D., Wilder R.M., Wilson I.D. Irritable colon and depression. Psychosomatics. 19:1978;540-547.
64. Steinhart M.J., Wong P.Y., Zarr M.L. Therapeutic usefulness of amitriptyline in spastic colon syndrome. Int J Psychiatry Med. 11:1981;45-57.
65. Myren J., Lovland B., Larssen S.-E., Larsen S. A double-blind study of the effect of trimipramine in patients with the irritable bowel syndrome. Scand J Gastroenterol. 19:1984;835-843.
66. Greenbaum D.S., Mayle J.E., Vanegeren L.E., et al. Effects of desipramine on irritable bowel syndrome compared with atropine and placebo. Dig Dis Sci. 32:1987;257-266.
67. Tanum L., Malt U.F. A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin. Scand J Gastroenterol. 31:1996;318-325.
68. Clouse R.E., Lustman P., Geisman R.A., Alpers D.H. Antidepressant therapy in 138 patients with irritable bowel syndrome a five-year clinical experience . Aliment Pharmacol Ther. 8:1994;409-416.
69. Lancaster-Smith M.J., Prout B.J., Pinto T., Anderson J.A., Schiff A.A. Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity. Acta Psychiatr Scand. 66:1982;33-41.
70. Blewett A., Allison M., Calcraft B., Moore R., Jenkins P., Sullivan G. Psychiatric disorder and outcome in irritable bowel syndrome. Psychosomatics. 37:1996;155-160.
71. Drossman DA, Li Z, Leserman J, Keefe F, Hu YJB, Toomey TC. Effects of coping on health outcome among female patients with gastrointestinal disorders, in American Gastroenterological Association. 1997: Washington, DC.
72. Petrosky M.J., Birkimer J.C. The relationship among locus of control, coping styles, and psychological symptom reporting. J Clin Psychol. 47:1991;336-345.
73. Kobak K.A., Greist J.H., Jefferson J.W., Katzelnick D.J. Computer-administered clinical rating scales. A review. Psychopharmacology (Berl). 127:1996;291-301.
74. Kobak K.A., Taylor L.H., Dottl S.L., et al. Computerized screen-ing for psychiatric disorders in an outpatient community mental health clinic. Psychiatr Serv. 48:1997;1048-1057.
75. Greist J.H. The computer as clinician assistant assessment made simple . Psychiatr Serv. 49:1998;467-468.
76. Kroenke K., Jackson J.L., Chamberlin J. Depressive and anxiety disorders in patients presenting with physical complaints clinical predictors and outcome . Am J Med. 103:1997;339-347.
77. O'Malley P.G., Wong P., Kroenke K., Roy M.J., Wong R.K. The value of screening for psychiatric disorders prior to upper endoscopy. J Psychosom Res. 44:1998;279-287.
78. Derogatis L.R., Lipman R.S., Rickels K., Uhlenhuth E.H., Covi L. The Hopkins Symptom Checklist (HSCL) a self-report symptom inventory . Behav Sci. 19:1974;1-15.